Impact of antibiotic treatment on bacterial resistance rates from patients with hospital-acquired infection

Journal of Chemotherapy

Volumn 19, Issue 6, 2007, Pages 673-676

  Bantar, Carlos ^a,b   Alcazar, G ^a   Franco, D ^a   Vesco, E ^a   Salamone, F ^a   Izaguirre, M ^a   Oliva, M E ^a  

^a HOSPITAL SAN MARTÍN   (Argentina)

^b NONE   (Argentina)

Author keywords

Antimicrobial resistance; Nosocomial infections; Resistance rates

Indexed keywords

AMIKACIN; CEFALOTIN; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; GENTAMICIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; CONTROLLED STUDY; ESCHERICHIA COLI; HOSPITAL INFECTION; HUMAN; INFECTION RISK; LABORATORY TEST; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; RISK FACTOR;

EID: 38949217000     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2007.19.6.673     Document Type: Article

References (11)

1. Owens RC, Jr., Rice L. Hospital-based strategies for combating resistance. Clin Infect Dis 2006; 42:S173-81.
2. Rybak MJ. Resistance to antimicrobial agents: an update. Pharmacotherapy 2004; 24 (12 Pt 2): 203S-215S.
3. Bosso JA. The impact of antimicrobial management on resistance. Pharmacotherapy 2004; 24 (12 Pt 2): 203S-215S.
4. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. NCCLS document M100-S13, NCCLS: Wayne, PA, 2003.
5. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16:128-140.
6. Bantar C, Famiglietti A, Goldberg M, The Antimicrobial Committee and The National Surveillance Program (SIR) Participants Group. Three-year surveillance study of nosocomial bacterial resistance in Argentina. Int J Infect Dis 2000; 4: 85-90.
7. Cook PP, Catrou PG, Christie JD, Young PD, Polk RE. Reduction in broad-spectrum antimicrobial use associated with no improvement in hospital antibiogram. J Antimicrob Chemother 2004; 53:853-9.
8. Bantar C, Sartori B, Vesco E, et al. A hospitalwide intervention program to optimize the quality of antibiotic use: impact on prescribing practice, antibiotic consumption, cost savings, and bacterial resistance. Clin Infect Dis 2003; 37:180-6.
9. Bantar C, Vesco E, Heft C, et al. Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance. Antimicrob Agents Chemother 2004; 48:392-5.
10. Landman D, Chockalingam M, Quale JM. Reduction in the incidence of methicillin-resistant Staphylococcus aureus and ceftazidime-resistant Klebsiella pneumoniae following changes in a hospital antibiotic formulary. Clin Infect Dis 1999; 28:1062-6.
11. Ti TY, Kumarasinghe G, Taylor MB, et al. What is true community-acquired urinary tract infection? Comparison of pathogens identified in urine from routine outpatient specimens and from community clinics in a prospective study. Eur J Clin Microbiol Infect Dis 2003; 22:242-45.